177
Participants
Start Date
September 30, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
Tapentadol
30 mg per administration, maximum 12 administrations over 48 hours
Matching Placebo
Maximum 12 administrations over 48 hours
Jean Brown Research, Salt Lake City
Lead Sponsor
Grünenthal GmbH
INDUSTRY